Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Large genome-wide association study identifies three novel risk variants for restless legs syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Amplicon sequencing provides more accurate microbiome information in healthy children compared to culturing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A novel homozygous GFI1B variant in 2 sisters with thrombocytopenia and severe bleeding tendency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genetic insight into sick sinus syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • DBDS Genomic Consortium
Vis graf over relationer

Soluble urokinase-type plasminogen activator receptor (suPAR) is a chronic inflammation marker associated with the development of a range of diseases, including cancer and cardiovascular disease. The genetics of suPAR remain unexplored but may shed light on the biology of the marker and its connection to outcomes. We report a heritability estimate of 60% for the variation in suPAR and performed a genome-wide association meta-analysis on suPAR levels measured in Iceland (N = 35,559) and in Denmark (N = 12,177). We identified 13 independently genome-wide significant sequence variants associated with suPAR across 11 distinct loci. Associated variants were found in and around genes encoding uPAR (PLAUR), its ligand uPA (PLAU), the kidney-disease-associated gene PLA2R1 as well as genes with relations to glycosylation, glycoprotein biosynthesis, and the immune response. These findings provide new insight into the causes of variation in suPAR plasma levels, which may clarify suPAR's potential role in associated diseases, as well as the underlying mechanisms that give suPAR its prognostic value as a unique marker of chronic inflammation.

OriginalsprogEngelsk
TidsskriftCommunications biology
Vol/bind4
Udgave nummer1
Sider (fra-til)655
ISSN2399-3642
DOI
StatusUdgivet - 2 jun. 2021

ID: 66131583